Hypoallergenic Proteins for the Treatment of Food Allergy.

Abstract

PURPOSE OF REVIEW:

Food allergy is a growing health problem worldwide that impacts millions of individuals. Current treatment options are limited and strict dietary avoidance remains the standard of care. Immunotherapy using whole, native allergens is under active clinical investigation but harbors the risk of severe side effects including anaphylaxis. Newer food-specific therapies with hypoallergenic proteins may potentially offer safer treatment alternatives, and this review seeks to investigate the evidence supporting the use of these modalities.

RECENT FINDINGS:

The utilization of different methods to alter allergen structure and IgE binding leads to reduced allergenicity and decreases the risk for systemic reactions, making the use of potential therapies including extensively heated egg/milk, peptide immunotherapy, recombinant allergen immunotherapy, and DNA vaccines safe and possibly efficacious forms of treatment in food allergy. However, for the majority of these treatment modalities, limited data currently exists looking at the safety and efficacy in human subjects with food allergy. This review provides a comprehensive overview of the current evidence examining the safety and efficacy of hypoallergenic proteins in the treatment of food allergies.

• Authors: Luanna Yang, Mike Kulis
• Journal: Current allergy and asthma reports (Curr Allergy Asthma Rep) Vol. 19 Issue 2 Pg. 15 (02 22 2019) ISSN: 1534-6315 [Electronic] United States
• PMID: 30796610 (Publication Type: Journal Article, Review)

Chemical References

• Allergens
• Peptides

Topics

• Adolescent
• Allergens (immunology)
• Child
• Child, Preschool
• Desensitization, Immunologic (methods)
• Food Hypersensitivity (therapy)
• Humans
• Infant
• Peptides (immunology)